Investors Research Corp’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23
Closed -$6.79K 818
2026
Q1
$6.79K Sell
23
-46
-67% -$13.7K ﹤0.01% 577
2025
Q4
$18.8K Hold
69
﹤0.01% 549
2025
Q3
$18.6K Hold
69
﹤0.01% 567
2025
Q2
$19K Hold
69
﹤0.01% 597
2025
Q1
$18.3K Hold
69
﹤0.01% 599
2024
Q4
$16K Sell
69
-16
-19% -$3.68K ﹤0.01% 624
2024
Q3
$18.8K Hold
85
﹤0.01% 616
2024
Q2
$16.7K Hold
85
﹤0.01% 648
2024
Q1
$18.3K Hold
85
﹤0.01% 631
2023
Q4
$17.9K Hold
85
﹤0.01% 657
2023
Q3
$17K Hold
85
﹤0.01% 676
2023
Q2
$15.8K Hold
85
﹤0.01% 695
2023
Q1
$16.3K Hold
85
﹤0.01% 708
2022
Q4
$14.3K Hold
85
﹤0.01% 714
2022
Q3
$15K Hold
85
﹤0.01% 690
2022
Q2
$17K Hold
85
0.01% 681
2022
Q1
$20K Buy
85
+16
+23% +$3.76K 0.01% 651
2021
Q4
$16K Hold
69
﹤0.01% 696
2021
Q3
$13K Hold
69
﹤0.01% 741
2021
Q2
$15K Hold
69
0.01% 712
2021
Q1
$14K Hold
69
0.01% 727
2020
Q4
$13K Hold
69
0.01% 807
2020
Q3
$12K Hold
69
0.01% 785
2020
Q2
$11K Hold
69
0.01% 782
2020
Q1
$12K Hold
69
0.01% 731
2019
Q4
$14K Hold
69
0.01% 778
2019
Q3
$15K Buy
+69
New +$14.4K 0.01% 771

Other funds holding CME

Investors Research Corp's CME Position: Q2 2026 in Review

Investors Research Corp sold out of CME Group (CME) in Q2 2026, closing a stake of 23 shares — an estimated $6.79K sold.

Investors Research Corp first reported a position in CME in Q3 2019 and held it in 27 quarters. The position peaked at $20K in Q1 2022. 334 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Investors Research Corp reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Investors Research Corp sold 23 CME Group shares in Q2 2026, an estimated $6.79K.
  • Investors Research Corp first reported a position in CME Group in Q3 2019 and held it in 27 quarters.
  • Investors Research Corp's CME Group position peaked at $20K in Q1 2022.
  • 334 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.